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In recent years, companies in the pharmaceutical industry have been confronted with a turbulent
environment characterized by dynamism, complexity and uncertainty. To cope with these changes and
achieve improved performance, these companies must generate the ability to make appropriate changes
in their organizations. For that reason, we use a quantitative methodology linear regression model to
investigate themultilevel resources, capacities and institutional aspects that inﬂuence the level of exports
of companies in Colombia’s pharmaceutical sector. The main ﬁndings that are highlighted include the
signiﬁcant role of the variables of supply costs, logistics, preview experience and the institutional envi-eywords:
harmaceutical
MEs export
esources view based
ronment in improving exports in the sector.
© 2015 AEDEM. Published by Elsevier España, S.L.U. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).nstitutional theory
ultivariate methodology
ntroduction
In recent years, companies have experienced a complex,
ynamicenvironment. Permanent changes in customers’ needsand
references have appeared, new products have been introduced,
ompetition has increased, uncertainty has become marked at the
ime of decision making, and new agents have appeared. The phar-
aceutical sector is no stranger to this situation: it is a sector in
hich it is very difﬁcult to predict the behavior of the environment.
or this reason, companies have been forced to work intensively to
eep up with the market’s changes. One of the pharmaceutical sec-
or’s primary characteristics is that its environment contains a large
umber of agents and components, and new products have been
evelopedas a result of technological progress (Rivera, Avila, López,
arzón, & Flores, 2010).
The pharmaceutical sector is also characterized by its require-
ent of large investments in research and development (R&D), its
roducts’ high renewalanddifferentiation rates, and thegeneration
 This article is the product of draft Networks and Innovation internationalization
f enterprises funded by the Pontiﬁcia Universidad Javeriana Cali (Colombia).
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http://dx.doi.org/10.1016/j.redee.2015.10.004
019-6838/© 2015 AEDEM. Published by Elsevier España, S.L.U. This is an open
icenses/by-nc-nd/4.0/).of beneﬁts for companies and patients, the latter through reduced
treatment costs and hospitalization days.
These characteristics encourage interactions between supply
anddemand in amarket environment that differs fromother indus-
tries. On the consumer side, the participation of various agents in
theacquisitionof goods is noteworthy; on the retailer side, themar-
ket power that companies acquire through the establishment of
legal monopolies, brand loyalty, and adverse selection is notewor-
thy. These features allowus to place the pharmaceutical industry in
a complex market scenario with multiple failures, creating incen-
tives for state intervention.
In Colombia, the pharmaceutical market features strong inter-
actions between private producers and public-sector distributors
because of the existence of a list of generic and essential medicines
to which those afﬁliated with social security are entitled, multiple
distribution channels, and a price regulation and market concen-
tration policy that often ignores the particularities of the sector.
In addition, the health care reform contained in Law 100 of 1993
modiﬁed some of the sector’s rules without considering the impact
of that change on the overall performance and achievement of the
healthcare system.
Sixty-seven percent of the Colombian pharmaceutical sector
is in the hands of national companies; international laborato-
ries compose the remaining 33% (ANDI, 2014). The trade balance
access article under the CC BY-NC-ND license (http://creativecommons.org/
4 Mana
o
g
i
b
t
C
c
b
p
c
a
t
t
a
t
t
A
C
t
C
a
l
k
g
M
t
h
o
c
C
t
a
i
p
T
c
n
N
t
r
i
s
d
w
o
m
u
w
H
p
m
a
p
m
t
p
b
p
c0 D.M. Escandón Barbosa et al. / European Journal of
f the Colombian pharmaceutical market is characterized by a
reater number of imports than exports because the sector relies on
mports from rawmaterials to ﬁnishedproducts. Therefore, Colom-
ia’s pharmaceutical sector has very strong international dynamics
hat are determined by this combination of exports and imports.
olombian companies in this sector must compete with foreign
ompanies. To do so, Colombian companies attempt to cut costs by
uying foreign raw materials and supplies.
In this paper, we present the dynamics of the Colombian
harmaceutical sector’s export activity. Factors that Colombian
ompanies confront in the pharmaceutical sector are identiﬁed,
long with their inﬂuence in export growth. In addition, we iden-
ify resources, capabilities and institutional factors that inﬂuence
he growth of exports in a quantitative study that achieves a close
pproximation of the sector’s reality. According to the results of
he Joint Survey of Industrial Opinions (Encuesta de Opinión Indus-
rial Conjunta—EOIC) conducted by the National Businessmen’s
ssociation of Colombia (Asociación Nacional de Empresarios de
olombia—ANDI) among businessmen in the pharmaceutical sec-
or during the third quarter of 2013, numerous problems affect the
olombian pharmaceutical sector. Based on that survey, this study
ims to verify whether variables such as productive resources,
ogistic capacity, previous experience on the international mar-
et and the institutional environment inﬂuence the sector’s export
rowth. Our hypotheses are supported by resource-based theory.
oreover, institutional theory and the regulatory function of insti-
utions are incorporated as the theoretical basis to support our
ypothesis that the institutional environment affects the growth
f the sector’s exports. This study ﬁnds that input costs, logistic
osts, previous experience and institutional environment affect the
olombian pharmaceutical sector’s exports, highlighting the sec-
or’s high dependence on imports of raw materials because of the
dvantages that other countries offer with respect to prices, lead-
ng to the domestic industry’s lack of initiative to increase domestic
roduction of raw materials.
he context of the Colombian pharmaceutical sector
The Colombian pharmaceutical industry is made up of national
ompanies, which control 67% of the domestic market, with inter-
ational laboratories or subsidiaries controlling the remainder.
evertheless, these foreign industries have developed produc-
ion and distribution strategies that have enabled them to reach
egions that previously had a minimal industry presence, resulting
n increased productive activity.
The Colombian pharmaceutical market is characterized by
trong interaction between private producers and public-sector
istributors; there is a list of generic and essential medicines to
hich those afﬁliated with social security are entitled; there are
nly two distribution channels, and there is a price-regulation and
arket-concentration policy that often ignores the sector’s partic-
larities (SENA, 2008).
In 1993, theNationalHealth System (SistemaNacional de Salud)
as restructured, creating the General System of Social Security in
ealth (Sistema General de Seguridad Social en Salud) and incor-
orating two instruments of drug policy: (1) essential drugs, as the
echanism to select the best drugs for the most common diseases;
nd (2) generic drugs, as the mechanism to introduce market com-
etition. Therefore, the Colombian drugmarket is composed of two
arkets derived from the twodrug-distribution channels: (1) insti-
utional, for the members of the social security system; and (2)
rivate. In both cases, there are critical differences in the distri-
ution channels to the ﬁnal consumer and there are substitution
ossibilities.
The Colombian pharmaceutical industry has undergone major
hanges in recent years, particularly after the issuanceof Law100ofgement and Business Economics 25 (2016) 39–46
1993. The social-security policywith respect to health that contains
this law has increased demand in the sector, especially for gener-
ics. This law also deﬁned the role of state regulators in drug-related
issues. One of the highest-impact standards for producers is Decree
549 of 2001,which implementsManufacturing Best Practices (Bue-
nas Prácticas de Manufactura—BPM) in all of the laboratories in
Colombia, thus enabling the sector to be more competitive and
productive (Bustamante, 2007).
Overall, the market for drugs has various classiﬁcation
criteria—e.g., mode of sale, type of products, therapeutic class,
and place of manufacture. In Colombia, the pharmaceutical indus-
try is very heterogeneous. It includes the production and import
of semi-elaborated pharmaceutical goods for ﬁnal consumption
by humans and animals. The industry directs a very small per-
centage of its expenditure to R&D expenses both because foreign
companies perform their research abroad and because domestic
companies can be considered small and medium sized; they do not
have enough resources to develop research programs to create new
drugs (Bustamante, 2007).
Moreover, thepresence ofmultinational companies inColombia
has declined in recent years. Several have taken their production to
other countries that offer greater tax incentives and fewer quality
and procedural regulations. This situation has encouraged national
laboratories to develop new products that meet domestic demand
formedicine (Stepanian& Tirado, 2013), thus transforming the sec-
tor into a strong exporter of drugs and an importer of rawmaterials
(Angulo & Mosquera, 2008). Exports of pharmaceutical products
have shown a growth trend since 2005, with a slight decrease
during 2010 and 2011. In the last two years, although exports
have continued to increase, there remains a trade-balance deﬁcit.
The sector’s strengths are its regulations in line with international
standards, freedom of prices, skilled labor, competitiveness, and
high-quality products; itsweaknesses are instabilities in the health
system, counterfeiting and smuggling, and control and surveillance
deﬁciencies (Angulo & Mosquera, 2008).
In recent years, Colombia has been characterized by a turbu-
lent business environment, with continuous changes in customer
needs and a resulting emergence of new products, increased price
competition and new players in the market. The pharmaceutical
sector has been affected by this dynamic; the behavior of its envi-
ronment has become more unpredictable and companies must not
only learn new skills to stay in business but also improve their
performance in developing skills and managing their resources to
adapt to new environmental conditions (Rivera et al., 2010). This
series of problems is reﬂected in the Joint Survey of Industrial Opin-
ions (Encuesta deOpinión Industrial Conjunta—EOIC) conductedby
the National Businessmen’s Association of Colombia (Asociación
Nacional de Empresarios de Colombia—ANDI) among businessmen
in the pharmaceutical sector during the fourth quarter of 2014. The
survey results showed a series of problems that affect Colombia’s
pharmaceutical sector. The primary obstacles perceived by busi-
nessmen include high levels of market competition, low demand,
the exchange rate, the cost and supply of raw materials, smug-
gling and unfair competition, and infrastructure and logistics costs.
The survey results also showed the presence of positive levels of
production and sales, stable inventories and a relatively favorable
business climate. One of the major topics of concern is the tax
reform being discussed in Congress because a higher income tax
represents a substantial burden on companies whose tax capacity
is at its limit. Another concern for entrepreneurs involves proposed
labor initiatives that could result in slower growth, less investment,
less employment and more informality (ANDI, 2014).Starting with problems speciﬁc to the pharmaceutical sec-
tor, this study analyzes the effects of the resources available for
production, logistics costs, previous experience and institutional
environment on the sector’s export growth. The following section
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huspresents the theoretical framework focusedon resource-based
heory and institutional theory, along with the hypothesis to be
ested.
heoretical framework
One of the most notable aspects of today’s economy is the new
orld order of international competition, trade blocs and global-
sm,which requires companies to participate in international trade,
egardless of a company’s size. This theoretical framework focuses
n analyzing the inﬂuence of particular resources, capacities and
he institutional environment on export growth.
esource-based theory and internationalization
Various business characteristics—typically, the possession of
ertain resources and capabilities that can be exploited in other
eographical markets at low costs (Buckley & Casson, 1976)—have
determining effect on export performance. Tallman (1992) states
hat a company decides to enter a foreign market based on an anal-
sis of its resources and capabilities that identiﬁes its competitive
dvantage.
Resource-based theory is drawn from the work of Penrose
1959), focusing on the theory of the growth of the ﬁrm, which
rgues that themain functionofbusiness is toacquire resourcesand
rganize for the purpose of producing goods and services that cre-
te proﬁtability. Among these resources, Penrose (1959) highlights
he need for personnel with experience and knowledge of the use
f other resources. Authors that followed Penrose (1959) deﬁned
hese resources as either tangible or intangible assets that compa-
ies control; these assets can be physical, technological, human,
tc. Therefore, companies’ competitive advantage will depend on
heexistenceof suchassets (Teece, 1980;Wernerfelt, 1984; Barney,
986, 1991; Peteraf, 1993; among others).
Overall, resource-based theory suggests not only that compa-
ies have heterogeneous resources and capabilities but also that
he extra beneﬁts obtainedby companies are the result either of the
ossession of valuable resources that constitute their competitive
dvantage or of the creation of speciﬁc capabilities that allow com-
anies to compete more successfully (Fong, 1998). Therefore, this
heory assumes that it is necessary to possess distinctive resources
hat are also “strategic”—that is, resources that are either valu-
ble or rare and difﬁcult to imitate or substitute (Barney, 1991;
eteraf, 1993; Teece, Pisano, & Shuen, 1997)—because if a com-
any possesses these types of resources, it is difﬁcult to ﬁnd other
ompanies with similar strategies for taking advantage of market
pportunities.
When a company’s various resources are broken down into cat-
gories, Weston and Brigham (1994) indicate that those categories
nclude physical resources (technology, plant, equipment, access
o raw materials, infrastructure and other factors that may affect
roduction costs), ﬁnancial resources (internal or external fund-
ng sources) and human-capital resources (classifying employees
y their respective competencies, including but not limited to edu-
ation level, experience, ability to make decisions, ability to adapt,
nd job skills) (Barney, 1991; Grant, 2006). Similarly, reference is
ade to organizational resources, organizational structure, levels
f authority, planning and control systems, and organizational cul-
ure (Barney, 1991; Grant, 2006).
In termsof capabilities, according toCardona (2011), these orga-
izational routines enable resources to be organized, integrated
nd complemented. Cardona draws on Grant (2006) to indicate
hat these routines are fundamental processes to transform oper-
tional and administrative practices into capabilities. Hamel and
rahalad (1990) argue that organizational capabilities not only aregement and Business Economics 25 (2016) 39–46 41
distinctive competencies of companies that are important for the
achievement of company objectives but also comprise different
individual tasks that often require the integration of specialized
knowledge.
Wang, Boateng, and Hong (2009) attempt to explain the process
of the internationalization of companies from three perspectives,
including resource-based theory, suggesting that international
expansion can occur when companies possess speciﬁc competi-
tive resources that can offset the additional costs associated with
entry into a foreign market. Therefore, the overseas expansion of
a business is seen as a means of appropriating income from for-
eign markets using valuable resources, which help reduce the costs
and risks incurred by the foreign market’s novelty and other dif-
ferences from the domestic market (Tseng, Tansuhaj, Hallagan, &
McCullough, 2007).
Another perspective used by Wang et al. (2009) to explain the
internationalization of companies is based on institutions; those
authors note that strategic decisions are not only promoted by
industry conditions and speciﬁc company resources but also reﬂect
the formal and informal constraints that result from a company’s
institutional framework (Scott, 1995). This viewpoint suggests that
every strategic decision is limited by various institutional forces
that can either promote or hinder the improvement of resources
and capabilities (Dunning & Lundan, 2008, cited by Wang et al.,
2009). Even strategies such as internationalization are developed
based on the institutional framework of the company’s country of
origin (Wan & Hoskisson, 2003). Below, the resources and capabil-
ities analyzed in this work are described.
Productive resources
According to Leonidou, Katsikeas, and Samiee (2002), compa-
niesmustoptimallyallocate their resources so that theycanachieve
higher export performance because resource availability enables
companies to exploit their opportunities and confront threats from
their environment. The determinants of export growth are seen
as external and internal inﬂuences, and the studies that exam-
ine the internal factors are grounded upon resource-based theory
(Beleska-Spasova, Glaister, & Stride, 2012). Within these internal
inﬂuences are operative, ﬁnancial, and human capital resources
(Beleska-Spasova et al., 2012). Operative resources include inputs
used to develop organizational processes. Therefore, the posses-
sion or lack of material resources affects export activity. Without
production resources, companies cannot satisfy the demand of
international markets, thus hampering export growth (Arteaga-
Ortiz & Fernández-Ortiz, 2010). In general, when the requirements
for export activities are incompatible with existing productive
resources, companies may experience poor export activity. In
addition, the high cost of required inputs can hamper business
participation in the international market, thus affecting the imple-
mentation of an export strategy (Beleska-Spasova et al., 2012). As
a result, the following hypothesis is proposed:
Hypothesis 1a. The high cost of productive resources negatively
inﬂuences the growth of exports.
Logistic resources and capabilities
Logistics represent a portion of the commercial costs of interna-
tional business activity and are critical for the volume of bilateral
trade (Anderson & Van Wincoop, 2004). When referring to logistic
costs, freight costs, customs, transaction costs, and documentation
(amongother things) are included. According toChang, Kaltani, and
Loayza (2009) and Hoekman and Nicita (2008), a country’s infra-
structure affects tradeandexport growth. The real costs of trade can
be substantially reduced by improvements in physical and logisti-
cal infrastructure that increase the volume of international trade.
When a country has many suppliers, adequate transportation,
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high-quality logistic infrastructure, several specialized logistic
perators, and a suitable cost and time requirement for compa-
ies to cross borders, international trade is facilitatedbecause these
esources are a major determinant of import and export volume
Hausman, Lee, & Subramanian, 2013). Accordingly, the following
ypothesis is presented:
ypothesis 1b. High logistic costs negatively inﬂuence the
rowth of exports.
revious experience
Human capital resources arise through training, experience and
anagement vision (Theingi & Purchase, 2011). Thus, managers
ith higher educational levels, knowledge of foreign markets and
xperience in international activities contribute toboostingexports
Ibeh & Wheeler, 2005; Maurel, 2009; Stoian, Rialp, & Rialp, 2011).
n this sense, Millington and Bayliss (1990) note the role of strate-
ic planning in the process of internationalization and conclude
hat during the ﬁrst wave of international participation, companies
ely on their market experience and therefore make incremental
djustments. However, as their degree of international experience
ncreases, companies’ planning systems formalize their strategic
nalysis and information search. The growth of international activ-
ty continues to the extent that experience can be translated across
ifferent markets and among various product groups, enabling
ompanies to use an incremental process within markets (Morgan
Katsikeas, 1997). Therefore, the following hypothesis is pre-
ented:
ypothesis 1c. Previous experience positively inﬂuences the
rowth of exports.
We started with resource-based theory to show the inﬂuence of
hepresenceof valuable resources andspeciﬁcorganizational capa-
ilities on companies’ internationalization decisions. However,
here are also environmental conditions that affect that decision.
ccording to Wang et al. (2009), those environmental conditions
re related to the institutional forces that are present in companies.
or that reason, institutional theory and its inﬂuence on interna-
ionalization are described below.
nstitutional theory and its inﬂuence on internationalization
Institutionalism considers that institutions are operating rules
or society and therefore have the ability to guide social processes
n all spheres: society, state and the market (Vargas, 2008). Insti-
utional theory states that institutions are created that are capable
f guaranteeing trust relationships among parties in conﬂict, solv-
ng problems of collective action, reducing transaction costs, and
educing incentives for corruption, among other tasks that ulti-
ately seek to maintain societal stability (Vargas, 2008).
According to Zucker (1987), institutional theory provides a
ision for organizations because organizations are inﬂuenced by
egulations, usually originating from external sources such as the
overnment but sometimes originating within the organization.
hrough institutional theory, various perspectives are presented in
hich the institution is theunit of analysis of economicandpolitical
eality. Among these perspectives, we present the most outstand-
ng. Economic institutionalism focuses on studying institutions as a
echanism to make decisions that allow a match between individ-
als’ preferences; therefore, institutions are rules and regulations
hat enable and constrain the behavior of social actors (North,
990; Scott, 2001). Economic institutionalism identiﬁes institu-
ions’ inﬂuence on countries’ economic and social performance,
here those countries’ preferences are explained according to
nstitutional guidelines (Vargas, 2008). The new economic institu-
ionalismdoesnot consider institutions’ social character; therefore,gement and Business Economics 25 (2016) 39–46
it is recognized that individuals’ rationality is determined by their
own limits to know all of the possible options for decision-making
(Hennings, 2007). Institutional political economy provides a basis
for governance because it holds that the institutional norms that
act on the behavior of individuals and their decisions are the
mechanisms that allow institutions to control those individuals’
behaviors, thus generating the logic through which organizations
must change (Weimer, 1995). In contrast, the new institutional
political economy analyzes the failures and deﬁciencies that occur
in state mechanisms and substantiates economic principles that
lead to efﬁciency.
This study is based on the approaches of the neo-
institutionalists, who express the need to study the existing
legal system and the means under which individuals’ actions
are restricted (Laurent, Ochoa, & Urbano, 2004). Government
activities can help companies develop competitive advantages
to develop in foreign markets those organizational capabilities
that they possess in their domestic markets (Westhead, Wright, &
Ucbasaran, 2002), which is why all government export-promoting
policies and industry regulations are considered external factors
that determine companies’ export behavior.
The institutional environment that inﬂuences the pharmaceuti-
cal sector’s international trade is analyzed in this paper, leading us
to frame this variable within institutional theory when consider-
ing the foreign-trade rules established by the State and conditions
imposed for foreign trade’s development. Moreover, institutional
theory suggests that to the extent that a company sees itself as part
of the world, it should progressively adopt rules and procedures
that give it legitimacywithin its ﬁeld, so that companies that decide
to export or import can expand their organizational ﬁeld, adapt-
ing to each country’s institutional environment to facilitate their
legitimacy in both local and global markets (Hessels & Terjesen,
2007).
The institutional environment
According to Araujo, Mion, and Ornelas (2012), export growth
depends on the quality of a country’s institutions of a country: a
good institutional environment can advance a distributor’s repu-
tation, especially because institutions impose strict restrictions on
its behavior. A country’s institutional characteristics reﬂect various
dimensions of the national environment framed in laws, rules and
regulations that either approve or restrict certain behaviors, which
is why institutions determine a company’s behavior, including its
internationalization activities (Novikov, 2014).
In Colombia, the issue of comprehensive quality control of
medicines (whether produceddomestically or entering the county)
has become a matter of great importance because of the opening
of the international market. The group that seeks control includes
associations such as Aﬁdro (with its framework for intellectual
property protection) and Asocoldro (which advocates for harsher
criminal punishment for those who commit smuggling and coun-
terfeiting). State organizations include the INVIMA (with its Drug
Surveillance Program) and DIAN (with its policy on the eradication
of smuggling). The regulatory framework is based on constitutional
principles and the right to enjoy a healthy environment. Other
important policies include the following: drug-price regulation;
health records; criminal sanctions for product adulteration; and
intellectual property protections. However, Colombia’s institutions
suffer from certain limitations, including a lack of infrastructure to
perform monitoring and control functions and to ensure compli-
ancewithbioequivalenceandbioavailability studies, a requirement
that in practice has not been implemented (Valbuena, 2006).
Hypothesis 2. A favorable institutional environment positively
inﬂuences the growth of exports.
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Table 1
Sample characterization.
Feature Domestic % Subsidiary % Total %
103 63.2 60 36.8 163 100.0
Age 0–10 31 30.1 15 25.5 46 28.4
11–20 25 24.3 17 27.9 42 25.6
21–30 19 18.4 13 21.3 32 19.5
31–40 17 16.5 3 5.1 20 12.3
41 or more 11 10.7 12 20.2 23 14.2
Total 103 100.0 60 100.0 163 100.0
Size Small 53 51.5 32 53.2 85 52.1
Medium 31 30.1 12 20.3 43 26.5
Large 19 18.4 16 26.5 35 21.4
Total 103 100.0 60 100.0 163 100.0
Location Bogota 51 49.5 27 45.4 78 48.0
Medellin 19 18.4 9 14.5 28 17.0
Cali 14 13.6 7 12.0 21 13.0
Barranquilla 10 9.7 6 10.5 16 10.0
Others 9 8.7 11 17.6 20 12.0
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ource: Own preparation, based on sample data.
ethodology
This quantitative research uses a database from a 2014 sur-
ey of a group of 400 exporting companies in Colombia. All of the
harmaceutical-industry companies were ﬁltered, resulting in a
ample of 163 companies. With these data, we intend to analyze
ome of the variables presented in the Joint Survey of Industrial
pinion (Encuesta de Opinión Industrial Conjunta—EOIC), which
s conducted annually by the ANDI. Through a multiple linear-
egression model, the inﬂuence of these variables on the growth
f exports in the sector is established.
The sample is composed of 103 domestic companies and 60
nternational companies with subsidiaries in Colombia. According
o their size, theywere classiﬁed as small,mediumor large depend-
ng on the number of workers. Thus, small businesses have 1–50
mployees, medium-sized businesses have between 50 and 200
mployees and large businesses have more than 200 employees. In
he sample, 52.1% are small, 26.5% are medium and 21.4% are large.
ost of these companies are located in Bogota (58%), followed by
edellin (17%), Cali (13%), Barranquilla (10%) and other cities (12%,
ncluding Cartagena and Bucaramanga). With respect to the age of
hese companies, 28.4% are between 0 and 10 years of age, 25.6%
re between 11 and 20 years of age, 19.5% are between 21 and 30
ears of age, 12.3% are between 31 and 40 years of age, and the
emaining 14.2% are more than 41 years of age (Table 1).
ultiple linear regression model
The research question and the assumptions made in this study
enerate the need to establish a model that enables us to include
usiness and industry variables. Therefore, a multilevel or hierar-
hical analysis is performed that allowsus to includevariousgroups
ngaging in the individual behavior, an approach that is character-
stic of traditional models (Liu & Gupta, 2007). This aggregation of
arious groups leads to better estimates of standard errors and dif-
erentiates the effects at the micro level (in this company research)
r the macro level (i.e., the sector), along with the relationships
etween levels, that is, in this research, the top-down processes
pproach (Klein, Dansereau, & Foti, 1994; Klein & Kozlowski, 2000)
s used to analyze inﬂuences generated from a higher level to a
ower level (i.e., sector to company).Multilevel models have primarily been used in the social sci-
nces and education because it is clear that society is organized in
estedhierarchies (Wu,1999). This typeof social order and theben-
ﬁts of this type of model are recognized; there has been a sharp60 100.0 163 100.0
increase in the use of this model in the last decade, although it
remains limited (. . ..).
Therefore, multilevel models are used in this research because
of the existence of possible differences in ﬁrm performance caused
by variables related to their economic sectors whose inﬂuence is
not directly revealed by traditional techniques (Snijders, 2011).
In other words, such models can identify differences associated
with individuals and the groups to which they belong while avoid-
ing a simple statistical aggregation of individuals and subsequent
generalizations that assume that all individuals interact with their
context in a similar manner (Draper, 1995).
In mathematical terms, it is proposed that the multilevel model
can be seen as an extension of the linear model, which explains a
dependent variable in response to a group of independent variables
as follows:
Y = xˇ + ε (1)
Where
Y = (y1 + y2 + y3 + . . .yn) is a vector of random answers.
yn: is the nth observation of the dependent variable. This vari-
able has the dimension (n×1).
Moreover, Xn is the nth observation of the independent variable
in the model.
Thus, x = (x1 + x2 + x3. . .. . .xn) is a matrix of size n ∗ p that
includes zeros, ones or existing independent variables in themodel.
ε= (ε1+ ε2+ ε3+ · · ·+ εn) is the error vector containing the unex-
plained with the independent variables included in the model; in
other words, these random errors result in the difference between
the observed and estimated values. Additionally, homoskedasticity
(equal variance for all values of X) is assumed.
Finally, ˇ = (ˇ1+ˇ2+ˇ3+ · · ·+ˇn) is the vector of the parame-
ters that reveal the weight of the variable in the equation and the
parameters to be estimated.
However, if the existence of the hierarchy or level within the
model is established and it is recognized that the individuals at the
micro level are clustered at themacro level, then the i-th individual
in the j-th group is expressed as follows:
Yij = ˇ0 + ˇ1jx1ij + ˇ2jx2ij + εij (2)
ˇ0j = ˇ0 + oj (3)
Where:
Yij: is the response of individual i in group j.
xij: is the explanatory variable in the individual i in group j.
εij: is the normally distributed error with constant variance.
ˇ0j: is the average of y and the j-th group.
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ˇ0: is the average of the population.
oj: is the random effect on the j-th group with variance 20.
Additionally, if the possibility of having different slopes for each
xisting group is presented, the following equation is obtained:
evel 1 : ˇ0 + ˇ1jx1ij + ˇ2jx2ij + εij (4)
evel 2 : ˇ0j = ˇ0 + oj; . . .ˇ1j = ˇ1 + 1j; . . .ˇ2j = ˇ2 + 2j
(5)
ith the column vector : = (oj +1j +2j)∼N(0,):  =
20
10 21
20 21 22
]
(eoij)∼N(0,e): e = (2e0).
It is important to note that because the dependent variable is
ot continuous, a multinomial logistic multilevel analysis is used
o capture the response options and the structure of the two levels
n the model. In general, if the reference category of the dependent
ariable is g, it is speciﬁed that
ij(s) = P(yij = 1)
Log
ij(s)
ij(g)
= ˇ0(s) + ˇ1(s)X1j + ˇ2
(s)Xij + . . . + 0(s); S = 1,2. . .g − 1
o(s)j∼N(0, 20(s))
h
g=1
ij(h) = 1
For this research, we seek to ﬁnd the model with the best ﬁt
ased on a theoretical model that contains the relationships that
e seek to contrast (Murillo, 2004). For this purpose, 4 steps are
roposed:
Model 1: A model is generated with the control variables.
Model 2: A model with variables related to the companies’
resources and capabilities is created.
Model 3: A model with the institutional variable associated with
theenvironment is created. Inmathematical terms, theﬁnalmodel
is expressed as follows:
Control Variables Resource V. Institutional V.
evel 2 : ˇ0j = ˇ0 + oj; . . .ˇ1j = ˇ1 + 1j. . .;ˇ2j
= ˇ2 + 2j. . .;ˇ3j = ˇ3 + 3j (7)
easurement of variables
To measure the dependent variable Growth of Exports, the sur-
ey question that asks whether the company has increased its level
f exports in the last 3 years is used. The responses are measured
sing the Likert scale from 1 to 7, in which 1 is strongly disagree
nd 7 is strongly agree.
To test the model, control variables such as the following are
roposed:gement and Business Economics 25 (2016) 39–46
(6)
AGE=Number of years the company has been in the market.
SIZE = Size of the company (small, medium or large).
OWNERSHIP=Ownership type (1 =national or 2 = international).
DSIQUI =Distance in kilometers to its main foreign market.
For independent variables, the following questions were
selected. These responseswere alsomeasuredonaLikert scale from
1 to 7, in which 1 is strongly disagree and 7 is strongly agree.
The resources and capabilities variables are as follows:
RPROD=Productive resources are measured using the following
question: Do you consider that the production costs of the sector
are high?
RLOG=Logistic resources are measured using the following ques-
tion: Do you consider the sector’s logistic costs to be high?
PREVEX=Previous experience ismeasured by the average number
of years that entrepreneurs in each sector claim to have performed
export activities.
The following institutional variable is proposed:
INSTE= Institutional environment is measured using the follow-
ing question: Do you consider the institutional environment to be
favorable for businesses?
Results
The estimated multilevel regression model yields the results in
Table 2. It should be clariﬁed that before estimating the model, the
statistical assumptions of the linear regression are veriﬁed, thus
validating the absence of distortions in the estimated relationships
in a linear regression model and conﬁrming the quality and reli-
ability of themodel results (Hair, Anderson, Tatham,&Black, 1999).
First, the independence assumption is validated, which estimates
either the absence of a relationship between residuals in the evo-
lution of the data or a no-correlation assumption. To this end, we
analyze the Durbin–Watson statistic, which provides information
about the degree of independence between the residuals, where
the residuals must not show any systematic pattern with respect
to either thepredictionsor the independent variables. If thevalueof
the Durbin–Watson statistic is close to 2 (approximately 1.5–2.5),
the residuals are independent; if it approaches 4, the residuals will
be negatively autocorrelated; and if it approaches 0, the residuals
will be positively autocorrelated (Hair et al., 1999). The statistic has
a value of 1.444, so the residuals’ independence is assumed.
Model 2 enables us to test the ﬁrst group of hypotheses. A posi-
tive relationshipbetweenProductionResources andExportGrowth
in the companies is perceived (Beta: 9.3244; sig. = 0.001), which
corroborates those hypotheses. Similarly, Hypothesis 1b is proved,
showing that the availability of Logistic Resources positively inﬂu-
ences the growth of exports of Colombian companies (Beta: 5.987;
sig. = 0.005). Finally, the positive relationship established in the lit-
erature between the Previous Experience and Export Growth is
shown (Beta: 10.5756; sig. = 0.005). After evaluating model 2 and
before evaluating model 3, the regression indicators obtained from
model 2 are analyzed to corroborate the explanation based on
the variables of the ﬁrm within Export Growth, concluding that
the variables are signiﬁcant and relevant within the investigation.
Subsequently, model 3 is tested, the institutional variable is incor-
porated and the hypothesis proposed at this level of analysis is
D.M. Escandón Barbosa et al. / European Journal of Mana
Table 2
Regression analysis results.
Model 1 Model 2 Model 3
Variables
Size 0.00345 0.00422 0.00363
Age 30.3431 30.6786 31.2864
Ownership 1.978 1.934 1.932
Psychological Distance 500 540 560
Resources and capabilities variables
RPROD (Hypothesis 1a) 9.3244 9.7854
RLOG (Hypothesis 1b) 5.987 6.6581
PREVEX (Hypothesis 1c) 10.5756 11.4009
Institutional variables
INSTE (Hypothesis 2) 5.3880
Adjusted R2 0.007 0.1317 0.2477
Change in R2 – 0.1247 1.16
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videnced. Hypothesis 2 is conﬁrmed, indicating that the insti-
utional environment positively inﬂuences Export Growth (Beta:
.3880; sig. = 0.001).
In summary, these results ﬁnd that although reports state that
he Institutional Environment is a problem that affects the phar-
aceutical sector, for the surveyed companies, it is not possible
o validate this result, particularly because this sector often must
ddress counterfeiting issues (for example, drugs may contain the
ncorrect active ingredient or the correct ingredient in incorrect
uantities) instead of smuggling (drugs entering illegally). This is
ecause of government regulations of the sector controlling the
ntry of smuggled drugs.
Export growth is adversely affected by the availability of Pro-
uction and Logistic resources. For both variables, we ﬁnd that the
igher the costs, the lower the studied companies’ export growth.
hencompanies in theColombianmanufacturing sectormustpur-
hase expensive supplies, their products became less competitive
n foreign markets because the selling price must also be high to
ecover the seller’s costs. For such companies, it therefore will not
e proﬁtable to export their products because their competitors’
upply costs are low, enabling them to offer low prices. The same
s true for logistical costs; if Colombian pharmaceutical companies’
ost of placing their products in foreign markets is very high, they
ose competitiveness in those markets, that is, it will be unfavor-
ble to export to other countries, especially countries in which the
harmaceutical sector beneﬁts from supplies and logistical costs at
ompetitive prices. Therefore, if pharmaceutical companies have
nsufﬁcient resources to fulﬁll their most important needs—e.g.,
urchasing inputs, labor, acquisition of new assets or replacement
f obsolete assets—they cannot continue to engage in export activ-
ties because it is probable not only that theywill be unable tomeet
certain level of productionbut also that theywill not have the cap-
tal to bear the additional costs associated with commercialization
n other markets.
onclusions
The Colombian pharmaceutical market is the fourth-largest
arket in Latin America. In recent years, the trend in this mar-
et has been to import and export products and/or raw materials.
he amendment to Law 100 of 1993 was one of the factors that led
o a more dynamic market and boosted domestic demand, result-
ng in higher revenues for companies. The social security system’s
ncreased drug coverage has resulted in a boost to the market for
eneric products; consequently, there has been an annual increase
n the import of inputs for manufacturing generic drugs. Similarly,gement and Business Economics 25 (2016) 39–46 45
national companies have been making inroads into foreign mar-
kets, especially in neighboring countries, because of their level of
competitiveness, production processes and sales strategies.
The results of this study support the conclusion that although
logistical costs are high in Colombia, it is still advantageous for
companies to continue to import raw materials; the beneﬁts of
importing still outweigh the costs of internal production. In addi-
tion, Colombia primarily produces drugs of low complexity; for
this reason, the market trend is weighted heavily toward importa-
tion either of raw materials or of drugs that are not manufactured
locally. In this sense, exchange-rate ﬂuctuation is one of the pri-
mary factors that can cause changes in supply and therefore would
have a negative effect on the exports because as a market importer
of raw materials, the Colombian pharmaceutical industry will be
limited by economic changes in the countries that export supplies
to the Colombian market.
In general, the reason for the high production costs associated
with supplies and logistics that affect the export growth of the
Colombian pharmaceutical sector is that the value of the drugs is
the sum of the costs and margins that comprise the price paid by
the ﬁnal consumer. In addition, a long chain of intermediaries adds
costs. Moreover, the pharmaceutical industry must employ qual-
iﬁed professionals given the need to provide products with high
quality standards that guarantee individuals’ health, thus increas-
ing production costs.
Nevertheless, the sector’s high costs—whether caused by
imported supplies, skilled labor, or logistics chains—result in the
sector’s companies prioritizing the ability to cover those costs to
reach a level of production that will, at minimum, allow them to
remain in the localmarket. Thus, exports are conditioned to speciﬁc
products that have a competitive cost advantage, such as natural
products (which have boomed because of Colombia’s signiﬁcant
biological diversity) or generic pharmaceuticals.
Overall, Colombia lacks advantageous resources and capabilities
in the pharmaceutical sector. Despite the industry’s technological
modernization, it does not attract the investment levels needed
to produce highly complex drugs. Because the government must
ensure the supply of drugs for the health system, Colombia is forced
to become an import-heavy market, dependent on countries with
valuable resources and capabilities.
From an institutional point of view, health policies seek to
provide greater coverage regardless of product quality, devoting
their efforts to increase coverage at any cost instead of investing
in knowledge and research to generate a range of drugs. However,
at the level of market regulation policies, notable positive results
are evident because medicine smuggling controls have increased.
The problem that companies often experience in the sector is the
growing threat of counterfeiting,which is exacerbated bynetworks
that introduce counterfeit products to the health system through
pharmacies, hospitals, distributors or the EPS, which are attracted
by the low prices offered. Thus, greater controls and special meas-
ures to counteract this problem are required, including continuous
inspections of distributors and industry customers to ensure that
drugs are stored in compliance with the sanitary conditions and
other provisions deﬁned by the Invima, from the composition of
the products to the packaging. These controls are necessary not
only because of the high level of drug adulteration and counterfeit-
ing but also because of the incorrect usage of legitimate drugs that
are sold irregularly or after their expiration, putting at users’ health
at risk.
Finally, this work enables us to consider some impacts on busi-
ness, government, academia and even consumers. In the business
sector, relevant aspects to assess the advantages and disadvantages
of the pharmaceutical sector have been identiﬁed, thus enabling
it to directly confront the issue of internationalization. Although
the focus of this study is some variables that affect international
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Wu, J. (1999). Hierarchy and scaling: Extrapolating information along a scaling lad-6 D.M. Escandón Barbosa et al. / European Journal of
rade, it is important for future studies to consider other variables
nvolved in the export growth of Colombia’s pharmaceutical sec-
or. This need is obvious in the results of goodness of ﬁt, which
ecognizes that the omission of other variables in the model could
xplain the export behavior of companies in the pharmaceutical
ector.
Next, we issue a call to the academy to continue its research
ork to address the needs and concerns of the economic sector and
o support business success. The disclosure of all of these studies is
n opportunity for companies to learn more about their environ-
ent and their industry and to identify opportunities, threats, and
otential.
The government is another important player because it deter-
ines public policy. Therefore, the results of this study enable the
dentiﬁcation of the shortcomings and merits of the government’s
conomic policy, thereby boosting the sector and attempting to
ncourage more export activity to improve the trade balance.
Finally, this study points to the importance of the consumer
ecause the pharmaceutical industry is responsible for providing
rugs. For that reason, proper import and export activity involves
ccess to quality medicines at reasonable costs.
Among the primary limitations of this study is its use of a cross-
ectionalmodel that belies the long-termevolution of the proposed
elationships. That said, this study does facilitate an understand-
ng of this sector’s behavior and weaknesses. Moreover, we ﬁnd
hat the sample, even though it is representative, is highly limited
ecause of the size of the sector inColombia.Nevertheless, the sam-
le allows us to establish the main conclusions provided in this
ection.
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